BioXcel Therapeutics shares pop after audit of Alzheimer’s trial data
October 25, 2023 at 08:44 AM EDT
Audit findings support application for approval of treatment for Alzheimer's-related agitation, company says
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|